The Role of NEWS on Intensive Care Discharges

Sponsor
Hitit University (Other)
Overall Status
Completed
CT.gov ID
NCT03626961
Collaborator
(none)
538
1
18.9
28.4

Study Details

Study Description

Brief Summary

To determine the ability of the NEWS at tertiary intensive care unit discharges to predict the development of clinical deterioration.

To determine a cut-off value for NEWS score for early readmission

Condition or Disease Intervention/Treatment Phase
  • Other: readmission
  • Other: discharge

Detailed Description

The Nationaly Early Warning Score (NEWS) is a single score based on the measurement of vital signs and inspired gases by the patient. A higher NEWS indicates severity of illness and risk of adverse outcomes. The use of NEWS values to select the appropriate patients for tertiary ICU discharges has not been tested. Our aim is to test the value of NEWS on discharges tertiary ICU.

Study Design

Study Type:
Observational [Patient Registry]
Actual Enrollment :
538 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
The Role of NEWS on Tertiary Intensive Care Discharges
Actual Study Start Date :
Dec 1, 2017
Actual Primary Completion Date :
Jan 1, 2019
Actual Study Completion Date :
Jun 30, 2019

Arms and Interventions

Arm Intervention/Treatment
discharge

patients discharged from icu

Other: readmission
Readmission after 48 hours

Other: discharge
Discharge

readmission

patients readmitted icu in 48 hours after icu discharge

Other: readmission
Readmission after 48 hours

Other: discharge
Discharge

Outcome Measures

Primary Outcome Measures

  1. Readmission rate [48 hours]

    Clinical deterioration within 48 hours after ICU transfer

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Older than 18 years old

  • Stay higher than 48 hours

Exclusion Criteria:
  • Under 18 years old

  • Stay lower than 48 hours

  • Intoxication

  • Exitus

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hitit university Çorum Corum Turkey 19100

Sponsors and Collaborators

  • Hitit University

Investigators

  • Study Chair: Ozgur Yagan, Assoc.Prof., Hitit universtiy

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Selcuk KAYIR, Medical doctor, Hitit University
ClinicalTrials.gov Identifier:
NCT03626961
Other Study ID Numbers:
  • 1
First Posted:
Aug 13, 2018
Last Update Posted:
Aug 6, 2019
Last Verified:
Aug 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Selcuk KAYIR, Medical doctor, Hitit University

Study Results

No Results Posted as of Aug 6, 2019